Aibo Ding (艾博定)艾博定

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

克拉屈滨是一种在国家药监局注册认定的药品。标注生产企业为海正辉瑞制药有限公司。

该药品暂无关联的活性成分信息。

该药品标注的生产企业为:海正辉瑞制药有限公司Chinese legal name: 海正辉瑞制药有限公司、海正辉瑞制药有限公司Chinese legal name: 海正辉瑞制药有限公司、海正辉瑞制药有限公司Chinese legal name: 海正辉瑞制药有限公司。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 艾博定) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 海正辉瑞制药有限公司.

No active ingredient relationships are currently recorded for this product in MedicineGraph.

Manufacturers recorded for this product: 海正辉瑞制药有限公司Chinese legal name: 海正辉瑞制药有限公司, 海正辉瑞制药有限公司Chinese legal name: 海正辉瑞制药有限公司, 海正辉瑞制药有限公司Chinese legal name: 海正辉瑞制药有限公司.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 艾博定Recorded Chinese name: 艾博定
  • 剂型Dosage form: 注射剂Injection
  • 规格Specification: 10ml:克拉屈滨10mg与氯化钠9omg。Recorded Chinese description: 10ml:克拉屈滨10mg与氯化钠9omg。

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

生产企业Manufacturer

  • 海正辉瑞制药有限公司Chinese legal name: 海正辉瑞制药有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20052240

关联实体Relationships

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20052240

Manufacturer

Chinese legal name: 海正辉瑞制药有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H20052240

生产企业

海正辉瑞制药有限公司(国产)

适应症

本品可试用于经干扰素治疗失败后活动性的伴有临床意义的贫血、中性粒细胞减少、血少板减少以及疾病相关症状的毛细胞白血病(HCL)治疗。

用法用量

本品溶于500ml生理盐水中缓慢静脉滴注、推荐用量为每次o.09mg/kg/d?连续7天为一疗程。

不良反应

1.常见副作用:发烧、头痛、头昏、恶心、腹泻。2.其他副作用:骨髓抑制(嗜中性球减少)。

禁忌

对克拉屈滨过敏者;怀孕妇女忌用。

注意事项

如有发烧、恶心或腹泻的情况,请立即通知医护人员。

贮藏

密封、遮光处保存。

规格

10ml:克拉屈滨10mg与氯化钠9omg。

证据Evidence

  • 批准文号: 国药准字H20052240
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.